儿科SARS-CoV-2临床样本中的病毒感染性不因年龄而异
Madaline M Schmidt1, Hannah W Despres1, David J Shirley2
1Department of Microbiology and Molecular Genetics, Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.
Access microbiology
|June 16, 2023
概括
感染SARS-CoV-2的儿童可以产生高水平的传染性病毒,无论年龄. 这项研究没有发现年龄对儿童群体严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 传染性的影响.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 儿科 儿科 儿科
背景情况:
- 在大流行初期,关于儿童在SARS-CoV-2传播动态中的作用存在不确定性.
- 儿童容易感染SARS-CoV-2,但通常比成年人体验的疾病不那么严重.
- 这种趋势在各种变体中持续存在,即使在未接种疫苗的儿科组中也是如此.
研究的目的:
- 为了研究在儿童中SARS-CoV-2感染性的潜在差异.
- 在儿科COVID-19病例中比较病毒RNA水平和传染性病毒标位.
主要方法:
- 分析了来自0-18岁儿童的144个SARS-CoV-2阳性临床样本.
- 病毒RNA水平的比较 (临床RT-qPCRCT值).
- 测量传染性病毒标位.
主要成果:
- 所有年龄段的儿童都能够产生高水平的传染性SARS-CoV-2.
- 在研究队列中,没有观察到年龄对病毒传染性的显著影响.
结论:
- 儿科年龄不会影响产生传染性SARS-CoV-2的能力.
- 儿童可以成为传染性病毒的重要来源,无论他们的年龄如何.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


